Hemophilia Center of Western Pennsylvania — Pittsburgh, Pennsylvania

Hemophilia Center of Western Pennsylvania is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213-4306.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Hemophilia Center of Western Pennsylvania has participated in 22 clinical trials with 8 currently active.

Therapeutic areas: Hemophilia A, Plasminogen Deficiency, Von Willebrand Disease (VWD).

Sponsors: Baxalta now part of Shire, BioMarin Pharmaceutical, Bayer.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hemophilia Center of Western Pennsylvania?

Hemophilia Center of Western Pennsylvania has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hemophilia Center of Western Pennsylvania conducted?

Hemophilia Center of Western Pennsylvania has 22 clinical trials on record, with 8 currently active. Their work covers Hemophilia A, Plasminogen Deficiency, Von Willebrand Disease (VWD).

Is Hemophilia Center of Western Pennsylvania accredited by Crixeo Health?

Yes — Hemophilia Center of Western Pennsylvania holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hemophilia Center of Western Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.